Oruka Therapeutics, Inc. ORKA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s common stock?
- Oruka Therapeutics, Inc. (ORKA) reported common stock of 545M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s common stock changed year-over-year?
- Oruka Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 545M to 545M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s common stock has grown at a 785.7% compound annual growth rate (CAGR), from 10K to 545M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).